$COR News
Last published 1w ago
- 1w agoCORCencora, Inc. - EX-99.1Earnings ReleasesForm 8-K - Current report - Item 2.02 Item 7.01 Item 9.01
- 1w agoCORBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Lumentum Holdings Inc. (Nasdaq – LITE), Surgery Partners, Inc. (Nasdaq – SGRY), Range Resources Corporation (NYSE – RRC), American Oncology Network, Inc. (OTCQX – AONC)GlobeNewswireBALA CYNWYD, Pa., Nov. 02, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky
- 2w agoCORBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Surgery Partners, Inc. (Nasdaq – SGRY), Range Resources Corporation (NYSE – RRC), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE – UTZ)GlobeNewswireBALA CYNWYD, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky
- 2w agoLEGNGILDAZNMCK+5Gabelli To Host 8th Annual Healthcare SymposiumGlobeNewswirePALM BEACH, Florida, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Gabelli is hosting the 8th Annual Healthcare Symposium in conjunction with Columbia Business School on Friday, November 13, 2026, at the Paley Center in New York.
- 3w agoCORBRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Passage Bio, Inc. (Nasdaq – PASG), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE – UTZ), Finward Bancorp (Nasdaq – FNWD)GlobeNewswireBALA CYNWYD, Pa., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky
- 3w agoCORAONCCencora to Acquire American Oncology Network to Strengthen Support of Community OncologyBusiness WireBuilds on Cencora’s MSO platform by adding complementary capabilities and expanding presence across twelve additional states Cencora, Inc. (NYSE:COR) today announced it has signed a definitive agreement to acquire
- 1mo agoCORCencora Announces Date and Time for Fourth Quarter Fiscal 2026 Earnings ReleaseBusiness WireCencora, Inc. (NYSE:COR) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2026 on Wednesday, November 4, 2026, prior to the opening of trading on the New York Stock Exchange. The
- 1mo agoCORCencora Elects Robert E. Sanchez to Its Board of DirectorsBusiness WireCencora, Inc. (NYSE:COR) today announced that its Board of Directors has elected Robert E. Sanchez as a new independent director, effective October 1, 2026. Mr. Sanchez is the Executive Chair of Ryder System, Inc.,
- 1mo agoCORBAIRD 2026 GLOBAL HEALTHCARE CONFERENCE - CENCORA INCEarnings Call TranscriptsI'm Eric Coldwell. It's great to have everyone here with us. We'll fix the mic. We'll have good questions. Bob Motch, CEO, Eva Borado, nice to have you with us as CFO. Thank you. This is, what, two months now? Three mont
- 1mo agoCORMorgan Stanley 24th Annual Global Healthcare Conference - CENCORA INCEarnings Call TranscriptsOkay, good morning, everyone, and welcome to the 24th Annual Morgan Stanley Global Healthcare Conference. I'm Erin Wright, Healthcare Services Analyst at Morgan Stanley. For more important disclosures, please see the Mor
- 3mo agoCORCencora Reports Fiscal 2026 Third Quarter ResultsBusiness WireRevenue of $84.8 billion for the Third Quarter, a 5.1 percent Increase Year-Over-Year Third Quarter GAAP Diluted EPS of $3.94 and Adjusted Diluted EPS of $4.48 Adjusted Diluted EPS Guidance Range Raised to $17.75
- 4mo agoCORCencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings ReleaseBusiness WireCencora, Inc. (NYSE:COR) today announced that it plans to release its results for the Third Quarter of Fiscal 2026 on Wednesday, August 5, 2026, prior to the opening of trading on the New York Stock Exchange. The
- 5mo agoCORCencora Appoints Eva Boratto as Executive Vice President and Chief Financial OfficerBusiness WireCencora reaffirms fiscal 2026 and long-term financial guidance Cencora, Inc. (NYSE:COR) today announced Eva C. Boratto has been appointed Executive Vice President and Chief Financial Officer of the Company, effective
- 5mo agoCORCencora Announces Updated Fiscal Year 2026 Financial OutlookBusiness WireThe Board of Directors authorized a new $2.0 billion share repurchase program Cencora, Inc. (NYSE:COR) today updated its fiscal year 2026 financial guidance as a result of recent opportunistic share repurchases.
- 6mo agoCORCencora, Inc. Q2 FY26 Earnings Call - Cencora, Inc.Earnings Call TranscriptsHello everyone, and thank you for joining us, and welcome to Sencora Inc Q2 2026 earnings call. After today's prepared remarks, we'll host a question and answer session. If you'd like to ask a question, please press star
- 6mo agoCORCencora Reports Fiscal 2026 Second Quarter ResultsBusiness WireRevenue of $78.4 billion for the Second Quarter, a 3.8 percent Increase Year-Over-Year Second Quarter GAAP Diluted EPS of $8.40 and Adjusted Diluted EPS of $4.75 Adjusted Diluted EPS Guidance Range Raised to $17.65
- 7mo agoCORCencora Announces Date and Time for Second Quarter Fiscal 2026 Earnings ReleaseBusiness WireCencora, Inc. (NYSE:COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2026 on Wednesday, May 6, 2026, prior to the opening of trading on the New York Stock Exchange. The Company
- 7mo agoCORCencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners' Retina BusinessBusiness WireCencora reaffirms fiscal 2026 financial guidance Cencora, Inc. (NYSE:COR) today announced the signing of a definitive agreement to acquire EyeSouth Partners' retina business for $1.1 billion. Upon completion of the
- 7mo agoCORCencora Announces Financial Leadership TransitionBusiness WireCencora reaffirms fiscal 2026 financial guidance Cencora, Inc. (NYSE:COR) today announced that James F. Cleary will retire as Executive Vice President and Chief Financial Officer effective June 30, 2026. Cencora has
- 8mo agoCORCovetrus and MWI Animal Health to MergeBusiness WireCombination of companion animal distribution, production animal distribution and technology platforms will make animal healthcare more accessible and affordable Transaction unites complementary businesses to deliver
- 9mo agoCORCencora Closes $3.0 Billion Senior Notes OfferingBusiness WireCencora, Inc. (NYSE:COR) today announced the closing of its public offering of $500 million aggregate principal amount of its 3.950% Senior Notes due February 13, 2029 (the "2029 Notes"), $500 million aggregate
- 9mo agoCORCencora, Inc. Q1 FY26 Earnings Call - CENCORA INCEarnings Call TranscriptsHello, everyone, and thank you for joining the CENCORA Fiscal 2026 First Quarter Results Call. My name is Lucy, and I'll be coordinating your call today. During the presentation, you can register a question by pressing s
- 9mo agoCORCencora Reports Fiscal 2026 First Quarter ResultsBusiness WireRevenue of $85.9 billion for the First Quarter, a 5.5% Increase Year-Over-Year First Quarter GAAP Diluted EPS of $2.87 and Adjusted Diluted EPS of $4.08 Adjusted Operating Income Guidance Raised to Growth of 11.5%
- 9mo agoCORCencora Elects Ellen Cooper to Its Board of DirectorsBusiness WireCencora, Inc. (NYSE:COR) today announced that its Board of Directors has elected Ellen Cooper as a new independent director, effective January 20, 2026. Ms. Cooper is the Chairman, President and Chief Executive
- 11mo agoCORCencora Accelerates OneOncology Acquisition, Extending Solutions Offering for Community OncologyBusiness WireCompany reiterates fiscal 2026 guidance Company raises long-term guidance expectations to reflect OneOncology's expected long-term contribution to enterprise growth Cencora, Inc. (NYSE:COR) today announced it has
- 1y agoCORCencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End ResultsBusiness WireRevenue of $83.7 Billion for the Fourth Quarter, a 5.9 Percent Year-Over-Year Increase Fourth Quarter GAAP Diluted EPS of $(1.75) and Adjusted Diluted EPS of $3.84 Revenue of $321.3 Billion for Fiscal Year 2025, a 9.3
- 1y agoCORIntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient OutcomesBusiness WireBiomarker data, enhanced therapeutic data and insights will enable biopharmaceutical innovation and physician support through informed decision-making IntrinsiQ® Specialty Solutions (IntrinsiQ), a leader in data
- 1y agoCORCencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings ReleaseBusiness WireCencora, Inc. (NYSE:COR) today announced that it plans to release its results for the Fourth Quarter of Fiscal 2025 on Wednesday, November 5, 2025, prior to the opening of trading on the New York Stock Exchange. The
- 1y agoCORCencora, Inc. (COR) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)Earnings Call Transcripts
- 1y agoCORCencora, Inc. (COR) Presents At Baird Global Healthcare Conference 2025 TranscriptEarnings Call Transcripts
- 1y agoCORCencora, Inc. (COR) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 TranscriptEarnings Call Transcripts
- 1y agoCORCencora Appoints Mark Durcan as Chairman of Its Board of DirectorsBusiness WireCencora, Inc. (NYSE:COR) today announced that its Board of Directors has appointed Lead Independent Director D. Mark Durcan as Chairman of the Board of Directors, effective October 1, 2025. Mr. Durcan will succeed
- 1y agoCORCencora, Inc. (COR) Q3 2025 Earnings Call TranscriptEarnings Call Transcripts
- 1y agoCORCencora Reports Fiscal 2025 Third Quarter ResultsBusiness WireRevenue of $80.7 billion for the Third Quarter, an 8.7 percent Increase Year-Over-Year Third Quarter GAAP Diluted EPS of $3.52 and Adjusted Diluted EPS of $4.00 Adjusted Diluted EPS Guidance Range Raised to $15.85 to
- 1y agoCORCencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings ReleaseBusiness WireCencora, Inc. (NYSE:COR) today announced that it plans to release its results for the Third Quarter of Fiscal 2025 on Wednesday, August 6, 2025, prior to the opening of trading on the New York Stock Exchange. The
- 1y agoCORCencora Elects Lori J. Ryerkerk to Its Board of DirectorsBusiness WireCencora, Inc. (NYSE:COR) today announced that its Board of Directors has elected Lori J. Ryerkerk as a new independent director, effective June 1, 2025. "Ms. Ryerkerk's experience in complex, global supply chains will
- 1y agoCORCencora Reports Fiscal 2025 Second Quarter ResultsBusiness WireRevenue of $75.5 billion for the Second Quarter, a 10.3 percent Increase Year-Over-Year Second Quarter GAAP Diluted EPS of $3.68 and Adjusted Diluted EPS of $4.42 Adjusted Diluted EPS Guidance Range Raised to $15.70 to
- 1y agoCORCencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings ReleaseBusiness WireCencora, Inc. (NYSE:COR) today announced that it plans to release its results for the Second Quarter of Fiscal 2025 on Wednesday, May 7, 2025, prior to the opening of trading on the New York Stock Exchange. The Company
- 1y agoCORCencora Announces Common Share Repurchase From Walgreens Boots AllianceBusiness WireCencora, Inc. (NYSE:COR) today announced that it has agreed to repurchase shares of its common stock from Walgreens Boots Alliance Holdings LLC in the amount of approximately $50 million in concurrence with Walgreens
- 1y agoCORWBAWalgreens Boots Alliance Early-Settles Certain Prepaid Variable Share Forward Transactions and Sells Related Shares of Cencora For Approximately $300 Million of ProceedsBusiness WireTransaction Highlights Walgreens Boots Alliance announces early settlement of certain prepaid variable share forward transactions with respect to shares of Cencora for delivery of an aggregate 6.1 million
- 1y agoCORCencora Reports Fiscal 2025 First Quarter ResultsBusiness WireRevenue of $81.5 billion for the First Quarter, a 12.8 Percent Increase Year-Over-Year First Quarter GAAP Diluted EPS of $2.50 and Adjusted Diluted EPS of $3.73 Adjusted Diluted EPS Guidance Range Raised to $15.25
- 1y agoCORHROWHarrow Partners with Cencora to Launch "Harrow Cares" Program, Making IHEEZO® and TRIESENCE® More Accessible and Affordable for Retina Specialists and Their PatientsBusiness WireHarrow (NASDAQ:HROW), a leading North American eyecare pharmaceutical company, today announced the launch of its "Harrow Cares" program through a strategic partnership with Cencora (NYSE:COR). Harrow Cares delivers a
- 1y agoCORCencora Announces Date and Time for First Quarter Fiscal 2025 Earnings ReleaseBusiness WireCencora, Inc. (NYSE:COR) today announced that it plans to release its results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025, prior to the opening of trading on the New York Stock Exchange. The
- 1y agoCORCencora Completes Acquisition of Retina Consultants of AmericaBusiness WireAcquisition Advances Specialty Leadership Adjusted Diluted EPS Guidance Range Raised to $15.15 to $15.45 for Fiscal 2025 Cencora, Inc. (NYSE:COR) today announced the completion of its previously announced
- 1y agoCORCencora Closes $1.8 Billion Senior Notes OfferingBusiness WireCencora, Inc. (NYSE:COR) today announced the closing of its public offering of $500,000,000 aggregate principal amount of its 4.625% Senior Notes due December 15, 2027 (the "2027 Notes"), $600,000,000 aggregate
- 1y agoCORCencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035Business WireCencora, Inc. (NYSE:COR) today announced that it priced $500 million aggregate principal amount of its 4.625% Senior Notes due December 15, 2027 (the "2027 Notes"), $600 million aggregate principal amount of its 4.850%
- 2y agoCORCencora, Inc. (COR) Q4 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoCORCencora Reports Fiscal 2024 Fourth Quarter and Year End ResultsBusiness WireRevenue of $79.1 Billion for the Fourth Quarter, a 14.7 Percent Year-Over-Year Increase Fourth Quarter GAAP Diluted EPS of $0.02 and Adjusted Diluted EPS of $3.34 Revenue of $294.0 Billion for Fiscal Year 2024, a 12.1
- 2y agoCORCencora Advances Specialty Leadership Through Acquisition of Retina Consultants of AmericaBusiness WireCencora, Inc. (NYSE:COR) today announced that it has entered into a definitive agreement to acquire Retina Consultants of America ("RCA"), a leading management services organization (MSO) of retina specialists, from
- 2y agoCORCencora Expands Enterprise Leadership Team with Two Senior AppointmentsBusiness WireFrancois Mandeville Named Executive Vice President, Strategy and M&A Pawan Verma Appointed Executive Vice President, Chief Data and Information Officer Cencora, Inc. (NYSE:COR) today announced the appointment of